✦ LIBER ✦

Antiplatelet and Anticoagulant Therapy for Stroke Prevention in Patients With Non-Valvular Atrial Fibrillation: Evidence Based Strategies and New Developments

✍ Scribed by Bernard J. Gersh; Jane E. Freedman; Christopher B. Granger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Updates on new oral anticoagulants and p

✍ Joey S.W. Kwong; Yat-Yin Lam 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Dual antiplatelet therapy is not optimal

✍ Á. Chamorro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Decision analysis and guidelines for ant

✍ Richard Thomson; David Parkin; Martin Eccles; Mark Sudlow; Angela Robinson 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 99 KB

PCV60 Cost-Effectiveness of Dabigatran f

✍ D. Tilden; P. Germanos; J. Gordon; L. Tocchini; B. Monz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Antithrombotic treatment for the primary

✍ Andrew Owen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 552 KB

Safety profile and efficacy of dabigatra

✍ A. Vilches-Moraga; J.C. Taboada-Rodriguez; C. Rodriguez-Pascual; E. Paredes-Galá 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 87 KB